Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hsin-Che Lin

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Alimentary Pharmacology & Therapeutics|April 26, 2024
Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients-Authors' replyHsin-Che Lin, Wen-Juei Jeng, Hwai-I Yang
Alimentary Pharmacology & Therapeutics|May 8, 2024
Editorial: High qHBsAg-Is it a good or bad signal? Authors' replyHsin-Che Lin, Wen-Juei Jeng, Hwai-I Yang
Clinical and Translational Gastroenterology|March 26, 2024
Response to Chen and LiawHsin-Che Lin, Wen-Juei Jeng, Hwai-I Yang
International Journal of Nanomedicine|May 23, 2018
SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo studyYi-Ping Fang, Chih-Hung Chuang, Yi-Jhun Wu, et al.
Pharmaceutics|November 6, 2019
High Potency of SN-38-Loaded Bovine Serum Albumin Nanoparticles Against Triple-Negative Breast CancerHsin-Che Lin, Chih-Hung Chuang, Meng-Hsuan Cheng, et al.
Clinical and Translational Gastroenterology|March 29, 2023
Rapid Decline Rather Than Absolute Level of HBsAg Predicts Its Seroclearance in Untreated Chronic Hepatitis B Patients From Taiwanese CommunitiesHsin-Che Lin, Jessica Liu, Mei-Hung Pan, et al.
Alimentary Pharmacology & Therapeutics|February 27, 2024
Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patientsHsin-Che Lin, Wen-Juei Jeng, Jessica Liu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Alimentary Pharmacology & Therapeutics|April 26, 2024
Letter: Association of persistently high HBsAg levels during HBeAg-seropositive stage and hepatocellular carcinoma risk in chronic hepatitis B patients-Authors' replyHsin-Che Lin, Wen-Juei Jeng, Hwai-I Yang
Alimentary Pharmacology & Therapeutics|May 8, 2024
Editorial: High qHBsAg-Is it a good or bad signal? Authors' replyHsin-Che Lin, Wen-Juei Jeng, Hwai-I Yang
Clinical and Translational Gastroenterology|March 26, 2024
Response to Chen and LiawHsin-Che Lin, Wen-Juei Jeng, Hwai-I Yang
International Journal of Nanomedicine|May 23, 2018
SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo studyYi-Ping Fang, Chih-Hung Chuang, Yi-Jhun Wu, et al.
Pharmaceutics|November 6, 2019
High Potency of SN-38-Loaded Bovine Serum Albumin Nanoparticles Against Triple-Negative Breast CancerHsin-Che Lin, Chih-Hung Chuang, Meng-Hsuan Cheng, et al.
Clinical and Translational Gastroenterology|March 29, 2023
Rapid Decline Rather Than Absolute Level of HBsAg Predicts Its Seroclearance in Untreated Chronic Hepatitis B Patients From Taiwanese CommunitiesHsin-Che Lin, Jessica Liu, Mei-Hung Pan, et al.
Alimentary Pharmacology & Therapeutics|February 27, 2024
Persistently high HBsAg levels during HBeAg-seropositive stage predict lower risk of hepatocellular carcinoma in chronic hepatitis B patientsHsin-Che Lin, Wen-Juei Jeng, Jessica Liu, et al.
Pageof 1